Bml Capital Management, LLC Atea Pharmaceuticals, Inc. Transaction History
Bml Capital Management, LLC
- $149 Billion
- Q1 2024
A detailed history of Bml Capital Management, LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 5,536,710 shares of AVIR stock, worth $20.2 Million. This represents 14.98% of its overall portfolio holdings.
Number of Shares
5,536,710
Previous 5,462,079
1.37%
Holding current value
$20.2 Million
Previous $16.7 Billion
34.27%
% of portfolio
14.98%
Previous 12.62%
Shares
4 transactions
Others Institutions Holding AVIR
# of Institutions
119Shares Held
49.6MCall Options Held
108KPut Options Held
327K-
Black Rock Inc. New York, NY9.24MShares$33.7 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.15MShares$22.4 Million0.71% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.72MShares$17.2 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA4.08MShares$14.9 Million2.01% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.49MShares$9.07 Million1.52% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $304M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...